Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104177357B details a Rh-catalyzed isoquinoline salt synthesis using oxygen. This method offers high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Patent CN101633647B details a novel four-step synthesis for alpha-azyl aryl alkyl ketones, offering superior yield and purity for reliable pharmaceutical intermediate supply chains.
Novel metal-free one-pot synthesis of 2-methylthio-maleic diesters offers high yield and cost reduction for pharmaceutical manufacturing supply chains.
Patent CN112573978A reveals a high-yield sulfoxide-catalyzed halogenation method offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthetic route for key herbicide intermediate offers shorter steps, milder conditions, and industrial scalability for global agrochemical supply chains.
Patent CN115448841A reveals a cost-effective silver-catalyzed method for synthesizing primary amines using ammonia water, offering significant advantages for pharmaceutical intermediate manufacturing.
Patent CN101643434B details a novel industrial synthesis of Agomelatine using 7-methoxy-1-naphthol, offering significant cost reduction and supply chain reliability for global manufacturers.
Novel titanate-catalyzed route for high-purity deuterated standards. Enhances supply chain stability and reduces forensic analysis costs significantly for global labs.
Patent CN101817835B reveals a novel pentafluorophenol activation route for Cefdinir, offering high purity, relaxed anhydrous conditions, and significant cost reduction in antibiotic manufacturing.
Patent CN109503472B details a mild, two-step photocatalytic route for heterocyclic sulfones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.
Patent CN101565427B details a green synthesis route for Cefdinir using low-temperature hydrolysis and recoverable solvents, offering significant cost reduction in pharmaceutical manufacturing.
Novel cyclic imide method for primary amines. Reduces waste, enhances supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing.
Patent CN115322116B details a green synthesis of nitriles from aldoximes using a stable solid promoter, offering cost reduction and safer supply chains for pharmaceutical intermediates.
Patent CN111471003A details a novel Negishi coupling route for sitagliptin intermediates, offering high purity and reduced steps for reliable pharmaceutical intermediate supply chains.
Patent CN102532030A reveals a mercury-free synthesis route for 2-iminoimidazoline-4,5-dione derivatives, offering high purity and scalable production for agrochemical and pharmaceutical applications.
Patent CN112028906A reveals a novel one-pot catalytic route for Pinoxaden. This method significantly reduces waste and operational complexity for scalable agrochemical intermediate manufacturing.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.